Enquiry

Specification Sheet

Retigabine, ≥98% (HPLC)

: D-23129, Ezogabine, N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester

: R 4896

: C16H18FN3O2

: 303.33

: Retigabine or ezogabine is an anticonvulsant used as an adjunctive treatment for partial epilepsies in treatment-experienced adult patients

: R 4896 (OTTO) Retigabine, ≥98% (HPLC) Cas 150812-12-7 - used as reagent in chemical research.


Properties

: Powder

: ≥98%

: Room temp


Safety Information
  • Environment
  • Skull and Crossbones

Signal word Danger
Hazard statements H301-H410
Precautionary statements P273-P301 + P310 + P330-P391-P501
RIDADR UN 2811 6.1 / PGIII
WGK Germany 3


PackingsPrice (INR)
10 mg 9909.00
50 mg 39906.00
1 gm POR